AUTO-ANTIBODY PROFILING OF NON-SMALL CELL LUNG CANCER


Year of Award:
2006
Award Type:
R41
Project Number:
CA118625
RFA Number:
RFA-CA-06-006
Technology Track:
Molecular & Cellular Analysis Technologies
PI/Project Leader:
HIRSCHOWITZ, EDWARD A
Other PI or Project Leader:
N/A
Institution:
20/20 GENESYSTEMS, INC.
Tumor markers, measured in peripheral blood, could assist in diagnosis and management of non-small cell lung cancer (NSCLC) and potentially improve historically dismal outcomes. Circulating antibodies, generated to a wide range of tumor-associated protein